To develop an in vitro model from explants of human varicose veins (VVs).
Procedures:
Segments of VVs were cultured for up to 14 days with 30% fetal calf serum. At 7 and 14 days, segments were analysed for changes in intima:media thickness and by immunohistochemistry. Comparisons were made with VVs at isolation and cultured explants of normal vein.
Results:
At isolation, VVs had a significantly thicker intima than normal veins (p<0.001). By day 7 in culture, normal veins developed a significant (smooth muscle cell-derived) ‘neo-intima’ (p<0.006). In contrast, in VVs there was little change in the intima but a significant increase in the thickness of the media (p<0.001). Following 14 days in culture, both the neo-intima in normal veins and thickened media in VVs had regressed. Overall, there was a reduction in the intima:media ratio in VVs by day 14 (p<0.03).
Conclusions:
Segments of VVs can be maintained in culture for up to 14 days without developing a neo-intima and may provide a suitable model to investigate mechanisms underlying the chronic venous insufficiency of varicosity.
SmithPD Coleridge. The management of chronic venous disorders of the leg: An evidence based report of an International Task Force. Phlebology [Suppl 1]1999; 14: 23–35.
2.
BrowseNLBurnandKGIrvineATWilsonNM. Diseases of the veins. 2nd ed.London: Edward Arnold, 1999:145–62.
3.
AbramsonJHHoppCEpsteinLM. The epidemiology of varicose veins: A survey in western Jerusalem. J Epidemiol Community Health1981; 35: 213–7.
4.
CoonWWWillisPWIIIKellerJB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation1973; 48: 839–46.
5.
BilandLWidmerLK. Varicose veins (VV) and chronic venous insufficiency (CVI): Medical and socio-economic aspects. Basle study. Acta Chir Scand Suppl1988; 544: 9–11.
6.
WidmerLK. Peripheral venous disorders: Prevalence and socio-medical importance. Observations in 4529 apparently healthy persons. Basle study III. Bern: Hans Huber, 1978.
7.
CallamMJ. Epidemiology of varicose veins. Br J Surg1994; 7: 27–30.
8.
BeagleholeR.Epidemiology of varicose veins. World J Surg1986; 10: 898–902.
9.
ArnoldiCC. The aetiology of primary varicose veins. Dan Med Bull1957; 4: 102–7.
10.
DoddHCockettFB. The pathology and surgery of the veins of the lower limb. Edinburgh: Livingstone, 1956:3.
11.
Cornu-ThenardABolvinPBaudJMVincenziICarpenterPH. Importance of the familial factor in varicose disease: Clinical study of 134 families. J Dermatol Surg1994; 20: 318–26.
12.
Corn-ThenardADabWde BinconziIValtyJ.Relationship between blood groups (ABO) and varicose veins: A case control study. Phlebology1989; 4: 37–40.
13.
McCauslandAM. Influence of hormones upon varicose veins. West J Surg1943; 51: 199.
14.
FarbiszewskiRGlowinskiJMakarewica-PlonskaNChwieckoMOstapowiczRGlowinskiS.Oxygen-derived free radicals as mediators of varicose vein wall damage. Vasc Surg1996; 30: 47–52.
15.
YamadaTTomitaSMoriMSasatomiESuenagaEItohT.Increased mast cell inflitration in varicose veins of the lower limbs: A possible role in the development of varices. Surgery1996; 119: 494–7.
16.
DebyCHaritonCPincemailJCogetJ.Decreased tocopherol concentration of varicose veins is associated with a decrease in antilipoperoxidant activity without similar changes in plasma. Phlebology1989; 4: 113–21.
17.
Garcia-RospideVPenafiel-MarfilRMoreno-PadillaFGonzalez-RiosJBrunoJJ RamosDieE. RosEnzymatic and isoenzymatic study of varicose veins. Phlebology1991; 6: 187–98.
18.
CrottyTP. Is circulating noradrenaline the cause of varicose veins?Med Hypotheses1991;34: 243–51.
19.
LaitinenMZacharyIBreierGPakkanenTHakkinenTLuomaJ, VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum Gene Ther1997; 8: 1737–44.
20.
ServosSZacharyIMartinJF. VEGF modulates NO production: The basis of a cytoprotective effect?Cardiovasc Res1999;41: 509–10.
21.
SoyomboAAAngeliniGDBryanAJJasaniBNewbyAC. Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol1990; 137: 1401–10.
22.
PorterKEVartyKJonesLBellPRLondonNL. Human saphenous vein organ culture: A useful model of intimal hyperplasia?Eur J Vasc Endovasc Surg1996;11: 48–58.
23.
TrendelenburgF.Ueber die Unterbindung der Vena saphena magna bei unterschenkel Varicen. Beitr Klin Chir1890–1; 7: 195–210.
24.
RoseSSAhmedA.Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg1986; 27: 534–43.
25.
ThompsonH.The surgical anatomy of the superficial and perforating veins of the lower limb. Ann R Coll Surg Engl1979; 61: 198.
26.
ThulesiusOUgaily-ThulusiusLGjoresJENeglenP.The varicose saphenous vein, functional and ultrastructural studies, with special reference to smooth muscle. Phlebology1988; 3: 89–95.
27.
TraversJPDaltonCMBakerDMMakinGS. Biochemical and histological analysis of collagen and elastin content and smooth muscle density in normal and varicose veins. Phlebology1992; 7: 92–100.
28.
LayerGTPattisonMEvansBDaviesDRBurnandKG. Tissue fibrinolytic activity is reduced in varicose veins. In: NegusDJantetG, editors. Phlebology '85. London: John Libbey, 1986.
29.
UrbanovaDPrerovskyI.Enzymes in the wall of normal and varicose veins: Histochemical study. Angiologia1972; 9: 53–61.
30.
WolfeJHNMorlandMBrowseNL. The fibrinolytic activity of varicose veins. Br J Surg1979; 66: 185–7.
31.
BoothRFMartinJFHoneyACHssallDGBeeselyJEMoncadaS.Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis1989; 76: 257–68.
